Long-term Outcomes of Ventricular Tachycardia Ablation in Different Types of Structural Heart Disease

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Ventricular tachycardia (VT) frequently complicates structural heart disease, including ischemic and non-ischemic cardiomyopathies.
• Implantable cardioverter-defibrillators (ICDs) improve survival for sustained VT but do not decrease arrhythmia frequency.
• ICD shocks correlate with increased morbidity and mortality, necessitating strategies to reduce them.

Purpose of the Study:

• To review the long-term outcomes of catheter ablation for ventricular tachycardia (VT) in patients with various structural heart conditions.
• To evaluate the impact of VT ablation on implantable cardioverter-defibrillator (ICD) shock burden.
• To clarify the potential mortality benefit of VT ablation in this patient population.

Main Methods:

• Systematic review of studies reporting long-term outcomes after VT ablation.
• Analysis of patient data stratified by underlying structural heart disease (e.g., ischemic cardiomyopathy, non-ischemic cardiomyopathy).
• Assessment of endpoints including VT recurrence, ICD shocks, and all-cause mortality.

Main Results:

• Catheter ablation effectively reduces the burden of ICD shocks in patients with VT and structural heart disease.
• Long-term success rates and impact on mortality vary depending on the specific type of structural heart disease.
• Further research is needed to definitively establish the mortality benefit of VT ablation.

Conclusions:

• Catheter ablation is a valuable tool for managing VT in structural heart disease, primarily by reducing ICD shocks.
• Patient selection and understanding the substrate are crucial for optimizing ablation outcomes.
• The role of VT ablation in improving long-term survival requires continued investigation.